Statement aims to alleviate concerns about lowering standards due to rush to find COVID-19 vaccine
Nine top US and European vaccine developers on Tuesday pledged to meet scientific standards when conducting experimental vaccinations as part of the global race to contain the coronavirus pandemic.
The signatories to the statement, including Pfizer, GlaxoSmithKline and AstraZeneca, made this “historic promise” amid concerns about declining safety and efficacy standards due to the rush to find a vaccine..
The companies said in a statement that they will “adhere to the scientific process” in developing and obtaining approvals for the first COVID-19 vaccines..
Johnson also signed the statement & Johnson, Merck & Co, Moderna, Novavax, Sanofi and BioNTech.
The head of the US Food and Drug Administration (FDA) said last month that COVID-19 vaccines may not qualify for Phase III clinical trials if officials are convinced the benefits outweigh the risks..
This prompted the World Health Organization (WHO) to issue a warning.
Developers around the world have yet to provide data from large-scale trials, but Russia registered a vaccine for COVID-19 last month, and some Western experts condemned the decision to approve the vaccine in the absence of large-scale testing..
The head of the Chinese company Sinovac Biotech said most of its employees and their relatives have already tested the experimental vaccine as part of the emergency use program..
Chinese companies and institutions involved in several leading vaccine development projects have not signed a statement.
BioNTech and Pfizer May Release Key Test Results As early as October.
The signatories pledged to follow the established recommendations of expert regulatory bodies, in particular the FDA.
S. Korean experts advise caution on using AstraZeneca’s COVID-19 vaccine on older adults The company is developing a vaccine with researchers from the…